REPL Replimune Group, Inc.
$12.47▲ +8.81%
Healthcare
Other
Volume 2.04M
Avg Volume (10D) 1.68M
Key Metrics & Fundamentals
Market Cap
$1.17B
P/E Ratio
–
Div Yield
0.00%
52W Range
1.50 - 16.33
% vs 50 MA
-7.49%
% vs 200 MA
36.54%
RSI-14
50.4
MACD Histogram
+0.0100
Beta (1Y vs SPY)
1.02
Free Cash Flow
-$75.73M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$67.70M
COGS
–
Operating Exp
$67.95M
Operating Income
-$67.95M
EBIT
-$67.95M
Pretax Income
-$69.77M
Net Income
-$69.77M
EPS (Diluted)
-0.72
Price & Volume History
Loading chart…
Recent News
Replimune to Report the Fiscal Second Quarter 2027 Financial Results and Provide Corporate Update on October 28, 2026
GlobeNewswire · Oct 22, 2026 8:00 AM ET
Replimune Group (REPL) Stock Looks Rich After A 141% Run
Simply Wall St. · Oct 17, 2026 12:14 PM ET
Replimune Group (REPL) Launches TUDRIQEV As Its Valuation Story Comes Into Focus
Simply Wall St. · Oct 9, 2026 11:12 AM ET
Replimune Receives Approval to Launch Tudriqev in the US for Melanoma
MT Newswires · Oct 1, 2026 4:33 PM ET
Replimune Announces TUDRIQEV™ Now Available in the U.S. for Advanced Melanoma
GlobeNewswire · Oct 1, 2026 4:01 PM ET
Trump Administration Shift Puts This Corner of Biotech Back in Favor
The Wall Street Journal · Sep 16, 2026 5:30 AM ET
Replimune to Present at the Cantor Global Healthcare Conference 2026
GlobeNewswire · Sep 3, 2026 8:00 AM ET
Why Did SJM, REPL, NEO Stocks Surge To 52-Week Highs Today?
Stocktwits · Aug 26, 2026 11:13 PM ET
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Aug 19, 2026 4:01 PM ET
Replimune Fiscal Q1 Net Loss Narrows
MT Newswires · Aug 14, 2026 8:26 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See REPL's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.